Phase I study of adjuvant immunotherapy using donor liver derived NK cells for preventing HCC recurrence after liver transplantation

Y. Imaoka,K. Sato, K. Imaoka,N. Tanimine,H. Tahara, K. Ide,T. Kobayashi, Y. Tanaka, A. Tzakis,S. Nishida, H. Ohdan, M. Ohira

TRANSPLANTATION（2022）

Cited 0|Views10

No score

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined